|
|
Middle East Journal of Cancer، جلد ۱۴، شماره ۱، صفحات ۱۷-۲۷
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
The Cytotoxicity of Tellurium Nanoparticles on Different Cell Lines and Their in vivo Anticancer Effects in an Animal Model |
|
| چکیده انگلیسی مقاله |
Background: Tellurium- containing compounds are suggested as the treatment agents for different diseases. This study aimed to synthesize tellurium nanoparticles (TeNPs) and study their in vitro and in vivo effects on tumour cells.Method: In this experimental study, the synthesis of TeNPs in an aqueous solution was achieved with lactose as a reducing agent. The cells (2×104) were seeded, in triplicate, in 96-well plates and exposed to different concentrations of TeNPs for 48 hours. The determination of cell viability was done by MTT assay. In vivo studies were performed using breast cancer-bearing mice treated with TeNPs at different doses via intraperitoneal (IP) and intravenous (IV) injections.Results: After 48 hours of treatment with TeNPs at different concentrations, cancer cell line viability was significantly decreased compared with control at almost all concentrations. Moreover, the IC50 of TeNPs in the non-cancerous cell line CHO (50.53 μg/mL) was far above that of EJ138 (29.60 μg/mL) and 4T1 (7.41 μg/mL) cell lines, revealing their lower toxicity in normal cells in comparison with cancer cells. The in vivo study's findings also showed that both delivery methods significantly inhibited tumor development, and that breast cancer-bearing mice lived longer than control mice, particularly when the largest dosage (400 μg, injected three times a week) was used.Conclusion: These results demonstrate TeNPs as promising therapeutic agents for cancer treatment. However, further investigation is still needed to determine the in vitro and in vivo anticancer mechanisms of TeNPs. |
|
| کلیدواژه‌های انگلیسی مقاله |
Anticancer, Cytotoxicity, Cell Line, Experimental mammary Neoplasm, Metal Nanoparticles |
|
| نویسندگان مقاله |
Ramak Ajideh |
Biotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran, Iran
Elnaz Faghfuri |
Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
Mina Hosseini |
Biotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran, Iran
Mohammad Hossein Yazdi |
Recombinant Vaccine Research Centre, Faculty of Pharmacy, Tehran University of
Medical Sciences, Tehran, Iran
Rouhollah Mirjani |
Department of Genetics and Advanced Medical Technology, Faculty of Medicine, AJA
University of Medical Sciences, Tehran, Iran
Zargham Sepehrizadeh |
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University
of Medical Sciences, Tehran, Iran
Ahmad Reza Shahverdi |
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University
of Medical Sciences, Tehran, Iran
|
|
| نشانی اینترنتی |
https://mejc.sums.ac.ir/article_48500_cb1218588057175202fc33f6796086bb.pdf |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|